logo

For the Inventor, By the Inventor

Albuquerque, NM, United States of America

Respira Therapeutics, Inc.


USPTO Granted Patents = 14


Trademarks = 2

Forward Citations = 42

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Martin J Donovan (14 out of 27 patents)

silverMedal Hugh Smyth (13 out of 13 patents)

bronzeMedal Robert Curtis (11 out of 14 patents)

4.  Zhen Xu (10 out of 32 patents)

5.  Revati Shreeniwas (7 out of 7 patents)

6.  Dan Deaton (6 out of 10 patents)

7.  James Hannon (6 out of 6 patents)

8.  Aileen Gibbons (5 out of 5 patents)

9.  Alain Romero (4 out of 4 patents)

10.  Adaani Frost (4 out of 4 patents)

11.  Jeffry G Weers (4 out of 60 patents)

12.  Pravin L Soni (3 out of 36 patents)

13.  Stephen Lermer (3 out of 3 patents)

14.  Jacques Pappo (2 out of 2 patents)

15.  Shirley Lyons (1 patent)


14 patents:

1. 12364701 - PDE5 inhibitor powder formulations and methods relating thereto (2025-07-22),
2. 12263174 - Methods and compositions for treatment of pulmonary hypertension and other lung disorders (2025-04-01),
3. 11911390 - PDE5 inhibitor powder formulations and methods relating thereto (2024-02-27),
4. 11806314 - PDE5 inhibitor powder formulations and methods relating thereto (2023-11-07),
5. 11491161 - Methods and compositions for treatment of pulmonary hypertension and other lung disorders (2022-11-08),
6. 11491160 - Methods and compositions for treatment of pulmonary hypertension and other lung disorders (2022-11-08),
7. 11471623 - Powder dispersion methods and devices (2022-10-18),
8. 10912778 - Methods for treatment of pulmonary hypertension (2021-02-09),
9. 10682476 - Powder inhaler, system and methods (2020-06-16),
10. 10525216 - Powder dispersion methods and devices (2020-01-07),
11. 10463815 - Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents (2019-11-05),
12. 10441733 - Powder dispersion devices and methods (2019-10-15),
13. 8651104 - Bead-containing dry powder inhaler (2014-02-18),
14. 8561609 - Dry powder inhaler (2013-10-22),
Company Overview
Respira Therapeutics, Inc. is a biotechnology company based in Albuquerque, NM, specializing in the development of innovative therapeutic solutions for respiratory diseases. The organization focuses on advanced drug delivery systems and inhalation technologies aimed at improving patient outcomes in the treatment of chronic respiratory conditions. By leveraging cutting-edge research and development, Respira Therapeutics is committed to enhancing the efficacy of respiratory therapies and addressing unmet medical needs in this critical healthcare domain.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Respira Therapeutics, Inc. USPTO Patent Assignee Logo
14 Patents

#44 in Albuquerque, NM

#59 in New Mexico

#22,319 in US

#42,249 in the World

Albuquerque, NM (US)
Albuquerque, NM, United States of America

Respira Therapeutics, Inc.

Forward Citations = 42

15 inventors:

goldMedal Martin J Donovan (14 out of 27 patents)

silverMedal Hugh Smyth (13 out of 13 patents)

bronzeMedal Robert Curtis (11 out of 14 patents)

4.  Zhen Xu (10 out of 32 patents)

5.  Revati Shreeniwas (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Respira Therapeutics, Inc.. Retrieved from https://idiyas.com/company/respira-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…